Manufacturer copay assistance · Takhzyro (J0593) · Takeda
$0/dose · Maximum benefit Annual program maximum applies — visit takedapatientsupport.com/copay for details · Covers Takhzyro drug cost-share — copay and coinsurance only
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Takhzyro — the program's cap applies against the patient share CareCost calculates.
Yes — Takeda Patient Support Co-Pay Assistance from Takeda. Eligible patients may pay $0 — program covers up to 100% of copay costs. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay $0 — program covers up to 100% of copay costs Maximum benefit: Annual program maximum applies — visit takedapatientsupport.com/copay for details. Covers Takhzyro drug cost-share — copay and coinsurance only
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.